Search Within

Neil Mukund Iyengar

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (68)
  2. Journal Article (58)
  3. Editorial (7)
  4. Review (7)
  5. Correspondence (6)
  6. Book Section (3)
  7. Research Letter (1)
Groups
  1. Breast Medicine Service (150)
  2. Department of Medicine (150)
  3. Population Sciences Research Program (150)
  4. Solid Tumor Oncology Division (150)
  5. Survivorship Research (150)
  6. Epidemiology and Biostatistics (43)

More Groups

People
  1. Clifford Hudis (57)
  2. Dilip Giri (31)
  3. Ayca Gucalp (29)
  4. Chau Dang (25)
  5. Monica Morrow (24)
  6. Patrick Morris (24)

More People

Years
  1. 2025 (4)
  2. 2024 (12)
  3. 2023 (13)
  4. 2022 (21)
  5. 2021 (13)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (36)
  2. Cancer Research (16)
  3. Oncology (Norwalk) (9)
  4. Cancer (7)
  5. Blood (6)
  6. Cancer Prevention Research (4)

More Publications

Publishers
  1. American Society of Clinical Oncology (37)
  2. American Association for Cancer Research (21)
  3. Elsevier Inc. (10)
  4. C M P Medica LLC * The Oncology Group (9)
  5. Wiley Blackwell (9)
  6. Nature Publishing Group (8)

More Publishers

Results (150)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The optimal living and survivorship program: Piloting a novel cancer survivorship care model
    Meeting Abstract

    Corcoran, S.; Russell, J.; Clayton, J.; Smith, A.; Keenan, K.; Robson, M.; Iyengar, N.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Obesity and energy balance considerations in triple-negative breast cancer
    Review

    Berger, E. R.; Iyengar, N. M.
    The Cancer Journal (2021)

    Fulltext@MSK | Save
  • Effects of obesity on breast aromatase expression and systemic metabo-inflammation in women with BRCA1 or BRCA2 mutations
    Journal Article

    Iyengar, N. M.; Zhou, X. K.; Mendieta, H.; El-Hely, O.; Giri, D. D.; Winston, L.; Falcone, D. J.; Wang, H.; Meng, L.; Ha, T.; more...
    npj Breast Cancer (2021)

    Fulltext@MSK | Save
  • The optimal living and survivorship program: Piloting a novel survivorship care model
    Meeting Abstract

    Corcoran, S.; Russell, J.; Clayton, J.; Kelly, B.; Smith, A.; Keenan, K.; Robson, M. E.; Iyengar, N. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Receipt of psychological counseling and integrative medicine services among breast cancer survivors with anxiety
    Journal Article

    Trevino, K. M.; Iyengar, N.; Li, Q.; Mao, J. J.
    Breast Cancer Research and Treatment (2020)

    Fulltext@MSK | Save
  • Developing a breast cancer tissue biobank in low and middle income countries (LMICs): A research program-based approach for improving molecular profiling
    Meeting Abstract

    Sharma, A.; Odujoko, O. O.; Alatise, O. I.; Edelweiss, M.; Ntiamoah, P.; Ogunleye, G. S.; Kingham, T. P.; Iyengar, N. M.; African Research Group for Oncology (ARGO)
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Lipid levels and survival after obesity-related cancer in the Women's Health Initiative CVD biomarker cohort
    Meeting Abstract

    Hovsepyan, G.; Lehman, A.; Thomson, C. A.; Iyengar, N. M.; Beebe-Dimmer, J. L.; Barac, A.; Shadyab, A. H.; Brasky, T.; Saquib, N.; Wild, R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • The optimal living and wellness program: Piloting a novel survivorship care model
    Meeting Abstract

    Corcoran, S.; Russell, J.; Smith, A.; Kelly, B.; Clayton, J.; Stein, B.; Keenan, K.; Robson, M. E.; Iyengar, N. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Extended mutational profiling by MSK-IMPACT™ identifies mutations predicting thromboembolic risk in patients with solid tumor malignancy
    Meeting Abstract

    Dunbar, A.; Bolton, K.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J. M.; Kelly, D.; Farina, M.; Kishore, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of gemcitabine with trastuzumab and pertuzumab after prior pertuzumab-based therapy among patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A phase 2 clinical trial
    Journal Article

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; more...
    JAMA Network Open (2019)

    Fulltext@MSK | Save